Call for Tighter Regulations Around Synthetic Cannabis – RTE
Synthetic cannabinoids patient safety is a growing concern due to unpredictable potency and unknown contaminants. These substances can cause severe adverse effects including psychosis and seizures. Tighter synthetic cannabis regulation is essential to…
Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I
The DEA has placed MDMB-4en-PINACA in Schedule I due to its high abuse potential and lack of accepted medical use. This synthetic cannabinoid poses significant health risks including seizures and psychosis. Awareness of MDMB-4en-PINACA Schedule I status…
26-CCC-18139-ACC Arrhythmogenic Potential of Synthetic Cannabis – JACC
Synthetic cannabinoids arrhythmia presents significant cardiac risks distinct from natural cannabis. This study highlights the arrhythmogenic potential of synthetic cannabis compounds. Clinicians must recognize these risks for proper cardiac assessment…
Acute and Long-Term Psychiatric Consequences of Synthetic Cannabinoids and Related Novel Psychoactive Substances: A Systematic Review
This systematic review examines psychiatric consequences synthetic cannabinoids cause, highlighting both acute and long-term effects. Synthetic cannabinoids present significant psychiatric risks distinct from natural cannabis. Understanding these…
Analytical Challenges and Emerging Detection Strategies of Synthetic Cannabinoids in Horse Doping Control.
Synthetic cannabinoid detection methods are critical in horse doping control due to the rapid evolution of these compounds. This article reviews the analytical challenges laboratories face in identifying synthetic cannabinoids. Understanding these…
Aryl-Cyclohexanone as a Potential CB2 Agonist: In Vitro and In Silico Evidence in Inflammatory Modulation.
Aryl-cyclohexanone cb2 agonist shows promise as a selective anti-inflammatory agent. This synthetic compound reduces inflammatory markers and supports immune modulation. Current evidence is preclinical, highlighting potential for future therapeutic…
‘Gas station heroin’ and other products parents should be aware of | Opinion
Synthetic cannabinoids toxicology is a critical concern with gas station drug products. These unregulated substances pose unpredictable health risks, especially for adolescents. Clinicians must recognize these dangers to provide effective care.
Acute Toxicity of ADB-CHMINACA – Case Series with Pronounced CNS Symptoms
This report presents a series of 16 patients with acute toxicity of ADB-CHMINACA confirmed by analytical testing. Patients exhibited pronounced central nervous system symptoms including panic attacks and seizures. The study highlights the dangers of…
Georgia Considers Synthetic Hemp Regulation Amid Medical Cannabis Expansion
Georgia is evaluating synthetic hemp regulation patient safety as it considers banning synthetic hemp products. This move aims to protect patients by distinguishing synthetic cannabinoids from regulated medical cannabis. Clinicians should monitor these…
Emergency Services Respond to Cannabis Sweets Hospitalizations
Cannabis sweets hospitalizations have raised concerns about the dangers of unregulated edibles. Emergency services responded after two individuals required urgent care due to these products. This highlights the clinical challenge of distinguishing…